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Endogenous steroid hormones and Endocrine Disrupting Chemicals (EDC) interact
with gut microbiota through different pathways. We suggest the use of the term
“endobolome” when referring to the group of gut microbiota genes and pathways
involved in the metabolism of steroid hormones and EDC. States of dysbiosis and
reduced diversity of the gut microbiota may impact and modify the endobolome
resulting at long-term in the development of certain pathophysiological conditions. The
endobolome might play a central role in the gut microbiota as seen by the amount
of potentially endobolome-mediated diseases and thereby it can be considered an
useful diagnostic tool and therapeutic target for future functional research strategies that
envisage the use of next generation of probiotics. In addition, we propose that EDC and
other xenobiotics that alter the gut microbial composition and its metabolic capacities
should be categorized into a subgroup termed “microbiota disrupting chemicals” (MDC).
This will help to distinguish the role of contaminants from other microbiota natural
modifiers such as those contained or released from diet, environment, physical activity
and stress. These MDC might have the ability to promote specific changes in the
microbiota that can ultimately result in common intestinal and chronic or long-term
systemic diseases in the host. The risk of developing certain disorders associated with
gut microbiota changes should be established by determining both the effects of the
MDC on gut microbiota and the impact of microbiota changes on chemicals metabolism
and host susceptibility. In any case, further animal controlled experiments, clinical trials
and large epidemiological studies are required in order to establish the concatenated
impact of the MDC-microbiota-host health axis.
Keywords: microbiota, endocrine disrupting chemicals, endobolome, hormones, endocrine pathogenesis,
microbiota disrupting chemicals
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INTRODUCTION
The effects of the bidirectional between steroid hormones and
gut microbiota on the development of diseases have been recently
reported (Kwa et al., 2016; Bajer et al., 2017). Hormones can have
an impact on the composition and metabolism of the microbiota.
In turn, the gut microbiome is highly involved in hormone
homeostasis through a number of possible mechanisms. The
concept “microgenderome” refers to the role of sex differences
in gut microbiota in relation to the incidence and comorbidity
of certain diseases (Mulak et al., 2014). An interesting example
of gut microbiome/hormones interactions is the role of sex
in type 1 diabetes found in a non-obese diabetic mouse
model that revealed that exposure of female mice to androgens
protected them from the disease (Fox, 1992; Markle et al., 2013),
which suggests the role played by sex-specific interactions in
disease development. The way this modulation affects hormone
metabolism, physiology, and pathophysiology is still unclear. The
gut microbiome can also modify hormone levels in the host by
participating in hormone biotransformation. A key triad of sex
hormones, host genotypic and phenotypic responses, and gut
microbiome has been proposed (Rosenfeld, 2017).
Previous research works have dealt with the effects of diet,
exercise and antibiotic use on host gut microbiome (Munyaka
et al., 2014; Murphy et al., 2015; Xu and Knight, 2015; Zhang
and Yang, 2016; Singh et al., 2017), but the effects of exposure
to exogenous chemicals on the microbiota have been poorly
investigated (Hu et al., 2016). Among these environmental
contaminants, the Endocrine Disrupting Chemicals (EDC)
have been recently defined by the Endocrine Society as: “an
exogenous [non-natural] chemical, or mixture of chemicals,
that interferes with any aspect of hormone action” (Zoeller
et al., 2016). This interference with the endocrine system
may result in biological, physical and metabolic disturbances
in humans. EDC can bioaccumulate up the food chain
and in the environment and that have been detected in
humans worldwide. These chemicals include dioxins, pesticides,
pyrethroids, polychlorinated biphenyls (PCBs), flame retardants
and, antibacterial such as triclosan (García-Mayor et al., 2012;
Darbre, 2017; Galvez-Ontiveros et al., 2020), plant derived
compounds found such as phytoestrogens and plasticizers
such as phthalates and bisphenol A (BPA). Exposure to EDC
might result in marked disturbances in the gut microbiome,
which in turn lead to widespread disruptions in several
host systems and damage of the commensal bacteria in the
host gut (Rosenfeld, 2017). However, the association between
misbalanced microbiota diversity or dysbiosis and possible
biological mechanisms responsible for the development of certain
diseases in different environmental exposure settings remains
largely unknown (Hu et al., 2016).
The term “estrobolome” was previously used to describe the
gut microbiota genes involved in the synthesis of estrogen-
metabolizing enzymes (Plottel and Blaser, 2011). We now suggest
the use of the term “endobolome” when referring to the group
of gut microbiota genes and pathways involved not only in
the synthesis of estrogens, but also in the metabolism of other
steroid hormones and endocrine disruptor chemicals. States
of dysbiosis and reduced diversity of the gut microbiota may
impact and modify the endobolome resulting at long-term in
the development of certain pathophysiological conditions. The
reduction in the diversity of microbial communities’ composition
and inflammation could decrease the enzymatic activity which,
sequentially, decreases the metabolization of hormones and EDC
into their modified, active or inactive and circulating metabolites.
This reduced availability of circulating hormones and EDC
results in changes in hormone receptor activation, which may
lead to the development of disorders related to demonstrated
hormone deficiencies such as obesity, metabolic syndrome, and
cardiovascular and related cognitive dysfunctions. Conversely,
endobolome can also stimulate the production of gut microbial
enzymes which leads to an increase in circulating hormones
which, in turn, increase the risk of diseases related with high
serum levels of hormones such as sex-hormone driven cancers.
The relevance of the crosstalk between EDC, hormones and
gut microbiota warrants a review of the current information
available on the interactions of these chemical disruptors with
sex steroid hormones and gut microbiota as well on the role
played by these interactions in the development of hormone-
related diseases.
ENDOBOLOME
New term to compile the group of gut microbiota 
genes, pathways and enzymes involved not only in 
the synthesis of estrogens, but also in the 
metabolism of other steroid hormones and 
endocrine disruptor chemicals in cohesion with 
their impact onto human health/disease balance.
ESTROBOLOME
It described the gut 
microbiota genes involved in 
the synthesis of estrogen-




Sex-related differences in gut microbome have been found
in human and mice experimental models. These differences
show a greater alpha diversity in the gut microbiome of
women (Falony et al., 2016), and lower abundance of Clostridia,
Methanobrevibacter, and Desulfovibrio in men (Falony et al.,
2016). As in humans, a larger alpha diversity was found in female
mice and a higher relative abundance of Bacteroidetes in males
(Yurkovetskiy et al., 2013; Kozik et al., 2017).
There is evidence supporting the idea that sex-dependent
differences in gut microbiome composition are related to sex
steroid hormones (Table 1). In this respect, some studies
have shown that gut microbiome in women differs from
that of men after puberty and that gonadectomy results in
disturbances in the microbiome or dysbiosis. For instance,
during infancy there were no differences in the microbiota
between fraternal twins of the same or different sex. Moreover,
in different- or same-sex fraternal twins no differences in gut
microbiota were found during childhood, but after puberty
significant structural differences in gut microbiome were found
in different-sex fraternal twins in comparison with same-
sex twins (Yatsunenko et al., 2012). Similar sex-dependent
changes were observed in rodent models after puberty (Markle
et al., 2013; Yurkovetskiy et al., 2013) and after gonadectomy





















TABLE 1 | Studies linking natural hormones, the related diseases and the effects on the microbiota.
References Animal model Microbiota
location
Dysbiosis/Related condition Microbiota changes
Studies in animals
Yuan et al. (2018) C57BL6 mice Gut • Endometriosis induced the dysbiosis. • Increased Firmicutes/Bacteroidetes ratio.
• Increased Bifidobacterium (phylum Actionobacteria).
Bailey and Coe (2002) Female rhesus
monkeys
Gut • Endometriosis is associated with an altered profile of
intestinal microbiota.
• Decreased Lactobacilli.
• Increased Gram-negative aerobic and facultative anaerobic bacteria.
Markle et al. (2013) Diabetic and
non-obese
diabetic mice
Gut • Childhood T1D may induce dysbiosis. • Commensal colonization resulted in increased serum levels of testosterone and protected
non-obese diabetic males from T1D.
• In young females, the transfer of gut microbiota from adult males resulted in microbiota
changes, with increased testosterone and metabolic changes, decreased inflammation of
pancreatic islets and autoantibody production, and protection against T1D.




Gut • PCOS may significantly alter the gut microbiome. • Decreased Lactobacillus, Ruminococcus, and Clostridium and increased Prevotella were
found in PCOS females. For Bifidobacterium, Escherichia coli, Enterococcus, and
Bacteroides there was no significant differences between PCOS females and the control
group.
• Gut dysbiosis was related to sex hormone levels, estrous cycles and morphological
changes in the ovaries.




Gut • PCOS may significantly alter the gut microbiome. • A significant decrease in the overall species composition and phylogenetic diversity of the
gut microbiota, particularly in the relative abundance of Bacteroidetes and Firmicutes, was
observed.
Studies in humans




• Altered microbiome in ovarian tumor tissue. • Increased Proteobacteria and Firmicutes.
• Decreased Bacteroidetes, Actinobacteria, Chlamydiae, Fusobacteria, Spirochaetes and
Tenericutes.
• Retroviridae, Hepadnaviridae, Papillomaviridae, Flaviviridae, Polyomaviridae and
Herpesviridae abound in > 50% of cancer samples.
• Pneumocystis, Acremonium, Cladophialophora, Malassezia, and Microsporidia
Pleistophora were significantly detected in all the ovarian cancer samples screened//in
100% of tumor samples examined.
Sfanos et al. (2018) Men Gut • Prostate cancer hormonal therapy may alter the gut
microbiota.
• Decreased alpha diversity in the gut microbiota of prostate cancer patients.
• A significant increase in Akkermansia muciniphila, Ruminococcaceae spp., and
Lachnospiraceae spp., was found in the fecal samples of prostate cancer patients
undergoing oral ATT. Additionally, a significant decrease in the number of sequencing reads
belonging to families such as Brevibacteriaceae, Erysipelotrichaceae, and
Streptococcaceae was also observed.
Golombos et al. (2018) Men Gut • An alteration of gut microbiota was observed in men
with prostate cancer.
• Increased Bacteriodes massiliensis in prostate cancer patients versus controls.
• Increased Faecalibacterium prausnitzii and Eubacterium rectale in controls versus
prostate cancer patients.
Liu et al. (2017) Women Gut • Disturbances in the gut microbiota of both obese and
non-obese women with PCOS compared to non-obese
controls.
• Decreased bacterial alpha diversity, increased LPS-producing bacteria, and decreased
spore-forming bacteria species.
• Increased Bacteroides and Escherichia/Shigella and decreased Akkermensia in obese
women with PCOS.
Fuhrman et al. (2014) Women Gut • Higher gut microbiota diversity was found in women
with a high hydroxylated estrogens metabolites/parental
estrogens ratio in urine.
• The relative abundances of the Clostridia class, including the Clostridiales order and the
Ruminococcaceae family, were directly associated with the ratio of metabolites to parental
estrogens, while the Bacteroides genus was inversely associated with this ratio.




















fmicb-11-578007 November 24, 2020 Time: 16:20 # 4
Aguilera et al. Endobolome, Microbiota, and Endocrine Pathogenesis
with a reduction in alpha diversity in ovariectomized mice
and rats (Moreno-Indias et al., 2016; Choi et al., 2017).
Ovariectomized mice showed decreased Bacteroidetes and
increased Firmicutes versus controls (Choi et al., 2017). In
male mice reduced Bacteroidetes and Ruminococcaceae were
observed after gonadectomy compared to controls (Harada
et al., 2016; Org et al., 2016). Future investigations should
examine acute versus long-term effects of gonadectomy (with
or without hormone replacement) in rodents and in other
species of mammals.
Microbiota, environmental and pathogenic bacteria have
the capacity to metabolize steroid hormones and their related
metabolites (Garcia-Gomez et al., 2013). Adlercreutz et al. (1984)
showed that disturbances in the gut microbiota secondary to
antibiotic therapy resulted in an increase in fecal estrogens
in women, which suggests the involvement of microbiota
in estrogen levels. Lombardi et al. (1978) demonstrated that
fecal microbiota may metabolize parent estrogens and their
metabolites. Fuhrman et al. (2014) demonstrated that high
estrogen metabolites/parent estrogens ratios related to increased
microbiota diversity in healthy postmenopausal women. In a
mouse model, Markle et al. (2013) showed that early-life changes
in gut microbiome result in increased testosterone and metabolic
changes that can suppress autoimmune diseases in genetically
high-risk animals while preserving fertility.
Gut microbiota can affect circulating levels of hormone
metabolites by deconjugation of the conjugated forms secreted
in bile and they can be subsequently reabsorbed through
the mucosal wall. Fuhrman et al. (2014) showed that estriol,
a hydroxylated estradiol metabolite, enters the enterohepatic
circulation, and that urinary and fecal levels of estriol and
parent estrogens are altered after antibiotic administration. They
also suggest that gut microbiota may differentially affect total
hormone levels as the association between total hormone and
microbiota diversity, which seemed to be stronger for metabolites
than for parent hormones. Lastly, they found higher gut
microbiota diversity in women with higher levels of hydroxylated
estrogen metabolites.
Shin et al. (2019) conducted a study in 31 men and 26
women and reported that sex steroid hormone levels are
correlated with gut microbial diversity and composition. In
men, they observed that testosterone levels were associated with
increased Acinetobacter, Dorea, Ruminococcus, and Megamonas.
In women, high estrogen levels were associated with increased
Bacteroidetes and decreased Firmicutes phyla. Lastly, a strong
association was found between Slackia and Butyricimonas and
estradiol levels.
The essential role played by gut bacteria in hormone
metabolism was described decades ago (Janssen and Kersten,
2015). Gut colonization by bacteria in germ-free mice resulted
in the regularization of the estrous cycle in females and
increased sperm counts in males, which in turn led to the
repair of fertility and reproductive capacities (Shimizu et al.,
1998). In a cross-sectional study conducted by Fuhrman et al.
(2014) that included 60 healthy postmenopausal women, the
authors examined the relationship between the composition
and diversity of microbiome, assessed trough 16S rRNA
gene sequencing, with measurements of urinary levels of
estrogens and their metabolites. Authors found a significant
correlation between microbiota diversity and the estrogen
metabolites/parent estrogens ratio in urine. Moreover, this ratio
increased with increased microbial phylogenetic diversity. These
findings support the hypothesis that differences in estrogen levels
and their metabolism significantly correlate with alterations in
gut microbial diversity.
All these studies compiled above revealed significant
evidence of hormonal regulation of the microbe-controlling
mechanisms, supporting sex differences in microbiota, in
addition to sex-specific responses to the same microbiota. The
relationship between microbiota, hormones and metabolism
seems multi-directional. Collectively, these studies indicate
that upcoming investigations into the composition and
function of the microbiota must carry on dividing data for
sex-differential interactions to understand these complex
connections more entirely.
HORMONE-GUT MICROBIOME AXIS
Muldireconal relaonships between 
microbiota, hormones and metabolism.  
Hormones exert regulaon of the microbe-
controlling mechanisms, supporng sex 
differences in microbiota, as well as sex-
specific responses to the same microbiota. 
The determination of the endobolome experimental
parameters may serve as potential biomarkers of certain
diseases (Figure 1). For example, the determination of
β-glucuronidases may help in the identification of some
specific bacterial species and, as mentioned above, this enzyme
might potentially increase the intestinal reabsorption of
endogenous hormones and EDC. Microbial β-glucuronidases
will process endogenous molecules like β-glucuronides of
hormones and exogenous β-glucuronides from the diet by
enabling these compounds to bind to hormone receptors and
subsequently produce their physiological effects (Baker et al.,
2017). Phytoestrogens also exert their activity via mechanisms
involving hormonal receptors. As mentioned above, increased
estrogen metabolites correlate with increased microbiota
diversity versus parent hormones in fecal samples (Fuhrman
et al., 2014). Additionally, a higher parent hormones/hormone
metabolites ratio correlates with an increased risk of breast
cancer (Samavat and Kurzer, 2015), obesity and other metabolic
diseases (Chen and Madak-Erdogan, 2016).
Interestingly, androgens also play a central role in sexual
physiology, and disturbances in their action are associated
with the development of different conditions in both men and
women. Collden et al. (2019) demonstrated that glucuronidases
produced by the cecal microbiota can degrade the high content of
testosterone and dihydrotestosterone found in the small intestine.
The high content of free or unconjugated dihydrotestosterone
found in the colon of healthy young mice of both sexes and men
suggests that gut microbiota might be involved in the metabolism
of intestinal androgens and can therefore affect the risk of
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FIGURE 1 | Endobolome: multiproxy approach to determine the influence of microbiota disrupting chemicals (MDC) in relation to specific endocrine pathogenesis.
androgen-related diseases in the distal intestine and probably also
in remote anatomical sites.
Identification of the bacterial genes in the gut microbiota
that encode enzymes responsible for the biotransformation of
endogenous steroids could explain potential interactions between
gut microbiome, host and the development of certain diseases.
In vitro studies have shown the capacity of gut microbiota to
the biotransformation of steroids. In this respect, Ervin et al.
(2019) conducted the first in vitro study to determine the capacity
of 35 β-glucuronidases of human gut to reactivate estrone-
3-glucuronide and estradiol-17-glucuronide to their parent
compounds. This supports the idea that the estrobolome is a
complex series of processes that occur in the gastrointestinal
tract of mammals and the probably involves different enzymes,
including distinct types of β-glucuronidases. Ridlon et al. (2013)
showed that Clostridium scindens may transform primary bile
acids to toxic secondary acids, and remove the two-carbon
side chain of glucocorticoids transforming them into androgens.
Doden et al. (2019) demonstrated that 20 β-hydroxysteroid
dehydrogenase from Bifidobacterium adolescentis can reduce host
glucocorticoids and thereby serve as potential probiotics for the
management of androgen-related conditions.
Another possible mechanism of interaction between EDC,
endogenous sex steroid hormones and gut microbiota is that
dysbiosis caused by EDC and hormone imbalance levels may
increase the permeability of the intestinal mucosa barrier in the
host. This would allow pathogens, LPS, toxins and metabolites
to enter the circulatory system thereby promoting chronic low-
grade systemic inflammation in the host, even targeting organs
like the brain (Fuhrman et al., 2014; Pickard et al., 2017).
Another potential mechanism involves the capacity of gut
microbiota to metabolize EDC and host hormones to produce
novel hormone receptor ligands (Schug et al., 2011). Additionally,
the microbiota may be modified in order to generate lower-
affinity hormones with endocrine functions but with a reduced
risk of developing hormone-responsive diseases like breast cancer
(Chen K. L. A. et al., 2018). It has been showed in a mouse
model that the status of hormone receptors such as estrogen
receptor β may alter microbiota composition and this microbiota
behaves differently to changes from diet complexity, promoting
Proteobacteria enrichment (Mulak et al., 2014). This suggests that
sex hormones have the capacity to mediate and modulate growth,
metabolism, and virulence of bacterial pathogens.
Bringing together all these findings allow us to validate the
theory that the endobolome implies a multidimensional set of
processes on-going inside the gastrointestinal tract that possible
involves many enzymes and pathways. The capacity of microbes
to control hormones and of hormones to modify microbial
diversity must be considered in future studies. Furthermore, it
is possible that in complex microbial communities the functions
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of hormone control could be diverse between different members
of the community. The detection of crucial microbial enzymes
in biodegradation might support to find microbial hormone
degradation routes and biomarkers of hormones metabolism by
a microbial community.
Moreover, we suggest that the gut may act a reservoir
for hormone metabolites that could exert effect locally and
possibly in the distance in systemic homeostasis and the
development of disease. Hormones and microbiota could exert
their activity separately for the development of disorders and
diseases; however, recent studies have shown that hormones
and microbiota may function together in conditions related
to hormone hypersecretion or deficiency (Tetel et al., 2018).
However, the way certain hormones alter the microbiome to
confer normal metabolic phenotypes or how microbial hormone
metabolites act as ligands binding to hormone receptors to
mediate metabolic functions (Fukui et al., 2018).
The communication between gut microbiota and hormones
guides to biological modifications through a diversity of tissues
ranging from neuronal development to reproductive health.
When dysibiosis occurs, these physiological responses are
altered and contribute to development of disease. Polycystic
ovary syndrome (PCOS) is a chronic metabolic disease in
reproductive-aged women with prevalence between 3 and
26% and whose pathogenesis is currently unknown. A novel
hypothesis suggests that microbiota dysbiosis may promote
the production of androgens in the ovaries which results in
disordered folliculogenesis triggered by a chronic inflammatory
response and insulin resistance (Tremellen and Pearce, 2012).
Kelley et al. (2016) found in a letrozole (a non-steroidal aromatase
inhibitor) induced PCOS murine model that treatment with
letrozole significantly changed the gut microbiome composition
in a time-dependent manner with a reduction in overall species
and phylogenetic richness. Guo et al. (2016) transplanted fecal
microbiota from healthy rats to letrozole-induced PCOS mice
and found that transplantation resulted in normalization of
the estrous cycles and the ovarian morphology. These findings
suggest the association between sex hormone levels, estrous
cycles, ovarian morphology and gut microbiota composition.
Another murine model study showed that transplantation of
male cecal microbiota to females led to increased testosterone
levels, compared with unmanipulated control females and female
mice transplanted with female cecal microbiota (Markle et al.,
2013). Liu et al. (2017) conducted a study in 33 PCOS patients and
found that gut dysbiosis correlated with the disease. The authors
also reported an increase in the relative abundance of Bacteroides,
Escherichia/Shigella, and Streptococcus in PCOS individuals, a
negative correlation between these bacterial species and ghrelin
levels, and a positive correlation with testosterone and body
mass index (BMI). Lastly, decreased abundances of Akkermansia
and Ruminococcus in PCOS, with a negative correlation of
these species and body-weight, sex-hormone, and brain–gut
peptides. Summarizing, human microbiota seems to play a key
role in endocrine and reproductive system disorders. Moreover,
microbiota reproductive dysbiosis have started to be treated
by probiotics using typical species from genus Lactobacillus
(Lopez-Moreno and Aguilera, 2020). Some Bifidobacteria seems
modulate sex hormone levels in patients with PCOS through the
gut–brain axis (Zhang et al., 2019).
The prostate is an estrogen and androgen target tissue
and estrogens have been shown to promote growth and
differentiation of prostate, potentially leading to the development
of prostate cancer. Recent studies indicate that gut microbial
species leading to increased serum levels of estrogens may
increase the risk of prostate cancer (Nelles et al., 2011).
Androgens are involved in the growth and survival of normal
prostate cells and in the development of prostate cancer, with
androgen suppression therapy being a usual treatment for this
type of cancer. However, although most patients with advanced
metastatic prostate cancer respond to androgen deprivation,
the tumors eventually become androgen-independent (Feldman
and Feldman, 2001; Porter et al., 2018). The capacity of gut
microbiome to alter androgen levels may result in depletion,
less effective androgen suppression therapy. Sfanos et al. (2018)
found a distinct microbial composition in patients undergoing
oral androgen suppression therapy versus patients not treated
with this therapy. Treated patients also showed an increase
in the bacterial metabolic pathways that stimulate androgen
synthesis. In addition, significant differences were found in the
gut microbial composition between prostate cancer patients
and patients with benign lesions (Golombos et al., 2018).
Similarly, Magri et al. (2018) considered prostatitis as a systemic
diseases correlating with alterations of specific microbiota or
seminal dysbiosis.
The relation between the gut microbiome and the
development of gynecologic cancers remains unclear (Mert
et al., 2018), but there is growing evidence of the role played
by changes in microbiome in an increased risk of these types
of cancers. It is plausible that all these factors can lead to
cancer by modifying the microbiota and its interaction with
host DNA or just simply by triggering inflammatory reactions.
Some possible mechanisms related to this increased risk are the
capacity of the microbiota to interact with the host DNA and to
promote chronic inflammation. As for epithelial ovarian cancer
patients, Banerjee et al. (2017) found a distinct gut microbiota
composition versus controls. Retroviridae and human papilloma
virus as well as Proteobacteria and Firmicutes were found in
ovarian cancer patients versus controls (Mitra et al., 2016).
In agreement with this hypotheses, probiotic microorganisms
are been investigating recently by their antigenotoxic potential
effects (Janosch et al., 2019).
Breast cancer has also been related with disturbances
in the microbiota. In this respect, it has been reported a
decreased gut microbial diversity and a different composition in
postmenopausal women with breast cancer versus controls (Zhu
et al., 2018). Lahiji et al. (2020) analyzed recently the effect of
symbiotic on glycemic profile and sex hormones in overweight
and obese breast cancer survivors following a weight-loss diet
through a randomized controlled trial. However, Jones et al.
(2019) did not found any correlation between fecal microbiota
and breast density on the mammograms.
As with gut microbiota, the enteroendocrine cells found in the
gastrointestinal tract can alter the microbial composition having
an effect on the intestinal health patterns of estrogen metabolism
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used as markers of breast cancer risk in postmenopausal
women have been correlated with gut microbiota diversity and
composition (Kwa et al., 2016).
Estrogens promote the growth and proliferation of epithelial
cells in the mammary gland and in the reproductive system
and are thereby associated with proliferative conditions like
endometrial cancer and endometriosis. Several authors have
suggested an association between gut microbiota alterations and
development of endometriosis (Ata et al., 2019). Bailey and Coe
(2002) supported this equivalent idea association in a rhesus
monkey model. In addition, in a murine model Yuan et al. (2018)
reported a distinct composition of gut microbiota 42 days after
endometriosis induction.
Taking together all this data shown that commensal
microbiota of the host could be implicated in gender bias existing
in numerous diseases. The capacity of the gut microbiome in
controlling hormone levels allow to have stimulating therapeutics
applications in different diseases, taken into account a sex-
tailored therapeutic approach.
Efficacy and safety of current hormone replacement therapies
might be improved by combining probiotics with the hormones
that work independently or synergistically to provide a more
holistic treatment approach against hormonal disease (De
Franciscis et al., 2019). Lastly, it has been suggested that probiotic
bacteria administered in combination with hormone replacement
therapy may increase the efficacy of hormone replacement and
attenuate the side effects that can arise from its use, therefore
providing a more comprehensive treatment of hormonal diseases.
Next generation probiotics will explore the function in this area
of knowledge (Ejtahed and Hasani-Ranjbar, 2019). The response
to therapeutic alteration of the microbiota using prebiotics, live
biotherapeutics or fecal transplant therapy is likewise probable to
be dissimilar in males and females, although this has not been
specifically studied to date.
The studies compiled revealed significant evidence of sex-
specific communities, the role of sexual maturation producing
changes to microbial communities, and proof that microbial
communities could have a key function by modulating hormonal
and metabolic pathways. Results highlight the need to examine
sex-specificity in microbial composition and function.
ENDOCRINE DISRUPTORS-GUT
MICROBIOME AXIS
The role played by human exposure to EDC in the development
of diseases such as breast cancer, diabetes, obesity and some
neurobehavioral disorders is widely known (Andujar et al., 2019).
These diseases have also been related to gut dysbiosis, which
suggests the central role of gut microbiome in the effects induced
by EDC exposure in human metabolism (Galvez-Ontiveros et al.,
2020). It can therefore be suggested that the exposure to EDC may
result in alterations in the gut microbiome which may ultimately
affect human health. In a bidirectional interaction, microbiota
can metabolize EDC to biologically active or inactive forms,
and EDC may induce the proliferation and growth of certain
bacteria. These EDC-induced changes in the gut microbiota
may lead to disturbances in different host systems. However, it
remains unclear if EDC-induced metabolic disruptions in the
host occur before the changes in the microbiome or if the EDC-
induced microbiome changes result in metabolic disruptions
(Rosenfeld, 2017).
The gastrointestinal tract is the main route of entry for EDC;
however, their absorption through the intestinal wall is low
and they are transported by the peristaltic movement to the
distal small intestine and caecum where microbial flora is more
abundant and they can be directly metabolized by the microbiota
thereby increasing or decreasing their toxicity to the host. Part of
the disruptors is taken to the liver by the portal circulation where
they are conjugated. These conjugated forms can be excreted
in the bile entering the small intestine where microbiota tend
to deconjugate them therefore restoring the original compound
or producing new toxic metabolites. EDC can also affect the
composition and metabolic activity of gut microbiota, which in
turn may result in a disrupted activity of EDC metabolites or
in the toxicity of other contaminants metabolized by the gut
microbiota (Claus et al., 2017). Data from animal models suggest
that the alterations in gut microbiota not only affect the levels
of microbial enzymes, but also the levels of hepatic enzymes in
the host (Snedeker and Hay, 2012). In addition, exposure to EDC
could alter gut microbiota functions.
The gut microbiota has the capacity to transform non-
EDC in active compounds. For example, Van de Wiele
et al. (2005) reported that colonic microbiota can metabolize
polyaromatic hydrocarbons into 1-hydroxy pyrene and 7-
hydroxybenzo[a]pyrene, biologically active estrogen metabolites,
while the gastrointestinal digestion of these xenobiotics did not
produce estrogen metabolites. This finding suggests that the
colonic microbial communities have the capacity to transform
parent compounds directly into active metabolites.
The hypothesis that exposure to EDC may result in alterations
of the gut microbial composition has not yet been extensively
explored. In this scenario, the microbiota and their products may
act as mediators of the effects caused by these contaminants,
which will eventually lead to the development of disorders and
diseases. Several EDC have been shown to promote dysbiosis
or to inhibit bacterial growth in in vitro and in in vivo models
(Galvez-Ontiveros et al., 2020). Dysbiosis has been associated
with intestinal and non-intestinal disorders which have been in
turn related to EDC exposure. This would be consistent with
the idea that EDC exposure may have an impact on the normal
gut microbiota colonization, which will ultimately affect host
physiology and health. These EDC-induced alterations of the
gut microbiota composition may represent an underestimated
mechanism of interfering with human health.
MICROBIOTA DISRUPTING CHEMICALS
(MDC)
We propose that EDC and other xenobiotics that alter the gut
microbial composition and metabolism should be categorized
into a subgroup termed “microbiota disrupting chemicals”
(MDC). This will help to distinguish the role of contaminants
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from other microbiota disruptors such as diet, environment,
physical activity and stress. These MDC might have the ability to
promote changes in the microbiota that can ultimately result in
intestinal, hormonal and chronic or long-term systemic diseases
in the host as illustrated in Figure 1.
Below we summarize the best known and studied by now
MDC and their effects on the microbiota.
EDC-GUT MICROBIOME AXIS 
Central role of gut microbiome dysbiosis 
linked to the effects induced by human 
EDC exposure that could trigger




EDC and other xenobiocs that 
alter the gut microbial composion 
and metabolism.  
Pesticides
Several studies have revealed the central role played by
gut microbiota in the toxicity of pesticides, with important
implications for environmental, animal and human health
(Yuan et al., 2019; Table 2). Glyphosate and chlorpyrifos, the
most widely used herbicide and pesticide, respectively, exhibit
endocrine disrupting activity. Human exposure occurs mainly
through diet and drinking water (Gillezeau et al., 2019). They
have been reported to interfere with gut microbial communities
and enteroendocrine cells (Li et al., 2019). Mucosal-associated
invariant T-cells (MAIT) are activated by bacterial-derived
metabolites from riboflavin and folic acid biosynthesis. Mendler
et al. (2020) investigated the effects of chlorpyrifos and glyphosate
on the regulation of MAIT activity but gut microbiota and
found that exposure to these pesticides results in disturbances
in the gut microbial communities studied, thereby promoting a
pro-inflammatory immune response.
In a fish model, chlorpyrifos led to disorders in the hepatic
lipid metabolism linked to oxidative stress in the gut and
dysbiosis (Wang et al., 2019). In a murine model, Liang et al.
observed that chlorpyrifos induced changes in the gut microbiota
which resulted in an increased risk of obesity and insulin
resistance (Liang et al., 2019). They also found that this pesticide
can disrupt the integrity of the intestinal barrier, leading to
the entry of lipopolysaccharides into the bloodstream ultimately
resulting in low-grade inflammation.
Using 16 S rRNA gene sequencing in a rat model, Tang
et al. (2020) observed that glyphosate exposure led to a
significant increase in α-diversity and changes in gut microbiota
composition with decreased relative abundance of Firmicutes and
Lactobacillus and enrichment of potentially bacterial pathogens.
Firmicutes produces butyrate as a byproduct of fermentation.
It has been reported that butyrate-producing bacteria play a
role in intestinal epithelial barrier maintenance (Canani et al.,
2011). Rueda-Ruzafa et al. (2019) showed that glyphosate-
mediated inactivation of 5-enolpyruvylshikimate-3-phosphate
synthase from intestinal microbiota results in dysbiosis which
in turn led to alterations in central nervous system causing
emotional, neurological and neurodegenerative disorders.
In a rat model, Li et al. (2019) investigated the effects of
chronic exposure to chlorpyrifos on serum hormone levels,
pro-inflammatory cytokines and gut microbiota and found that
exposure significantly decreased levels of luteinizing hormone,
follicle stimulating hormone and testosterone and change gut
microbiota composition. The affected bacteria included short-
chain fatty acid-producers, which stimulate the hypothalamic-
pituitary-adrenal axis and the immune response, and increase the
permeability of the gut barrier.
Diazinon, an organophosphate pesticide with estrogenic
activity (Manabe et al., 2006) has shown to alter the structure
of the gut microbiome community, functional metagenome, and
their associated metabolic profiles in a sex-related manner in
murine models (Gao et al., 2017a). Gao et al. (2017a) suggest that
diazinon neurotoxicity and its sex-dependent effects are related
to the pesticide-induced alterations of the gut microbiome and
its functions. The same authors (Gao et al., 2017b) investigated
the effects of diazinon exposure by determination the gut
bacterial metatranscriptome. They demonstrated that diazinon
has the capacity to regulate quorum sensing, a system used to
regulate bacterial population density and composition, and more
importantly, their functional genes. Lastly, they also found that
diazinon exposure results in the activation of stress response
pathways and in disruptions of energy metabolism of gut bacteria.
Organochlorine pesticides with endocrine disrupting capacity
have been also related with alterations in gut microbiota.
Dichlorodiphenyldichloroethylene (DDE) exposure of 3-week-
old male Sprague Dawley rats led to an increase of fat and body
weight, dysregulation of glucose homeostasis, and promoted
dysbiosis as suggested by a higher Firmicutes/Bacteroidetes ratio,
resulting in disruptions in energy harvesting. DDE also resulted
in alterations in the lipid metabolome profile with high plasma
concentrations of phosphatidylcholine, phosphatidylserine,
hosphatidylethanolamine, and triacylglycerol. The presence of
these lipid metabolites was significantly associated with changes
in microbiota composition (Liang et al., 2008).
Bisphenol and Phthalates
Bisphenol A (BPA) is an environmental contaminant with
endocrine disrupting activity widely used in the manufacture
of polycarbonate plastics and epoxy resins and is released in
large volumes into the environment. Phthalates are used in
many household products and in food packaging acting as
binding products and plasticizers. Human exposure to these
contaminants occurs mainly through the diet, as they leech
from plastic packaging, water, dust and to lesser extent from
skin contact (Larsson et al., 2017). Both endocrine disrupters
have shown to affect gut microbiota composition and function
in animal models (Table 3). In a mouse model, DeLuca et al.
(2018) found that BPA has the capacity to promote colonic
inflammation and alter the levels of tryptophan and other
microbiota metabolites derived from aromatic amino acids
related to autoimmune diseases, specifically to inflammatory
bowel conditions. In a mouse model, Lai et al. (2016) used
16S rRNA gene sequencing of cecal microbiota to demonstrate
that BPA exposure through diet may result in alterations
of gut microbiota composition and function, promoting the
growth of Proteobacteria, a marker of dysbiosis, that has been
associated to different disorders such as metabolic syndrome
and inflammatory bowel disease (Zhang et al., 2006). Increased


























Microbiota changes Health effects
In vitro studies





• The growth of E. coli, Bifidobacterium adolescentis
and Lactobacillus reuteri was not inhibited.
• E. coli activated a significantly higher number of MAIT cells to produce TNFα and IFNγ
after exposure to CPF. However, B. adolescentis and L. reuteri did not induce activation of
MAIT cells per se after exposure to CPF or GLP.
• E. coli decreased riboflavin production after exposure to CPF. In contrast, folate
production by E. coli was significantly increased after exposure to CPF.
• GLP exposure resulted in MAIT cell activation by E. coli, but exposure did not affect
vitamin production.
• Exposure to CPF and, to a lesser extent, GLP, can result in bacterial metabolism changes,
with imbalances in the levels of activation/inhibition of bacterial metabolites that could have
an impact on the inflammatory immune responses.
Studies in animals
Wang et al. (2019) Zebrafish CPF (30,
100, and
300 µg/L)
• Significant decrease in γ-Proteobacteria. • CPF induces oxidative stress.
• Exposure to CPF could induce liver disorders of glucose and lipid metabolism in adult
zebrafish.





• Decreased Bacteroidetes phyla.
• Increased Proteobacteria phyla.
• Exposure to CPF resulted in disrupted integrity of the intestinal barrier, which increases
the entry of lipopolysaccharides into the body and lastly low-grade inflammation.
• Increased fat mass.
• Decreased insulin sensitivity.






• Decreased Firmicutes phylum and Lactobacillus
genus.
• Increased pathogenic bacteria Clostridium botulinum.
• GLP exposure decreased the villus height/crypt depth ratio in the duodenum and jejunum
which is associated to decreased digestive and absorptive capacity.
• Decreased activity of antioxidant enzymes
• GLP exposure promotes the production of proinflammatory factors (IL-1β, IL-6, TNF-α,
MAPK3, NF-κB and Caspase-3).




• Increased relative abundances of Streptococcus,
Ruminiclostridium, and norank_f_Coriobacteriaceae in
adult rats exposed to CPF.
• Reduced relative abundances of Corynebacterium_1,
Psychrobacter, Facklamia, norank_f__Peptococcaceae,
Oligella, Brevibacterium, Catabacter, Dietzia,
Atopostipes and Ignavigranum in newly weaned rats
exposed to CPF.
• Decreased concentrations of luteinizing hormone, follicle-stimulating hormone, and
testosterone were found in rats exposed to CPF and fed normal-fat diet. The counteracted
effect of the high-fat diet was also found in intestinal hormones and pro-inflammatory
cytokines.
• TNF-α were found in newly weaned rats exposed to CPF, whereas only peptide YY,
ghrelin and IL-6 increased significantly in rats exposed in adulthood.




• Decrease in several genera of the Lachnospiraceae
family in exposed male and female mice.
• High prevalence of pathogenic bacteria
(Burkholderiales and Erysipelotrichaceae_Coprobacillus)
was only found in exposed male mice. As well as
increased Bacteroidetes phylum and decreased
Firmicutes.
• Lachnospiraceae, Ruminococcaceae, Clostridiaceae
and Erysipelotrichaceae decreased in female mice.
• Tryptophanase was significantly downregulated in male mice but not in females.
• Glycine was decreased in male mice, but not in females.
• Exposure to diazinon resulted in disturbances of bile acid metabolism in both male and
female mice, but the patterns and involved metabolites were sex dependent. Lithocholic
acid and cholesterol increased in males. Lithocholic acid also increased in females, but with
decreased cholesterol.




• Intestinal dysbiosis was observed in the previous
study (Gao et al., 2017a).
• Altered quorum sensing mechanisms.
• Increased motility and genes related to sporulation.
• Activation of stress response pathways.
• Impaired metabolic homeostasis of carbohydrates, fatty acids, and amino acids.














































Microbiota changes Health effects
In vitro studies




• Increased abundance of Lactobacillus and Parabacteroides.
• Decreased abundance of Fluviicola and Enterococcus.
• Exposed cultured microbiota increased the production of metabolites typically
associated with fermentation of sugar and amino acid residues.
• Among the metabolites detected are potentially toxic compounds derived
from aromatic amino acid. Metabolites normally found in low concentrations in
the intestine of healthy individuals but in high concentrations in developmental
disorders were also detected [3-phenylpropionic acid and 3- (3-hydroxyphenyl)
propionic acid are precursors of 3- (3 -hydroxyphenyl) -3 hydroxypropionic].
Studies in animals




_ • Exacerbation of colon inflammation in animals with dextran sulfate
sodium-induced colitis.
• Reduction of fecal tryptophan and aromatic amino acids.




• Increased phylum Proteobacteria and Helicobacteraceae family.
• Decreased Firmicutes and Clostridia.
• Absorption of BPA in the diet affects gut microbial composition, which relates
with increased risk of metabolic disorders and inflammatory bowel disease.




• Exposure to BPA in P0 females resulted in increased
Mogibacteriaceae, Sutterella spp. and Clostridiales. BPA exposure of
F1 females resulted in increased Bifidobacterium and the family
Mogibacteriaceae.
• In P0 males exposure led to increased abundance of Mollicutes and
Prevotellaceae and increased. Akkermansia and Methanobrevibacter in
F1 males
• BPA binds to and activates the estrogen receptors.
• Many bacterial genera associated to EDC exposure are also found in several
diseases such as inflammatory bowel disease, metabolic disorders, and
colorectal cancer.
Malaise et al. (2017) Mice BPA (50
µg/kg)
• Decreased bifidobacteria and Clostridium. butyricum and Clostridium
Cluster XIVa.
• Obesogenic impact of early and intrauterine exposure to BPA.
• Glucose intolerance and decreased insulin sensitivity were observed in young
and adult mice perinatally exposed to BPA.
• Perinatal BPA exposure may also result in a loss of intestinal barrier.
Chen et al. (2018a) Zefrafish BPA (0, 2,
and 20
µg/L)
• BPA exposure in male fish resulted in increased abundance of
Actinobacteria at 13.9% (P < 0.001), Hyphomicrobium, and Lawsonia.
• Single BPA exposure in female fish resulted in increased abundance
of Actinobacteria to 15.7% (P < 0.001) and Hyphomicrobium.
• Exposure to 2 µg/L BPA resulted in decreased body weight in male fish
versus controls, also in a significant reduction of the condition factor, and
decreased intestinal levels of serotonin.
• No significant differences in body length, body weight, or condition factor
were observed in female fish. Single exposure to BPA resulted in significantly
higher intestinal levels of serotonin versus controls.
• Decreased levels of intestinal IL1β were observed in males versus significantly















































Microbiota changes Health effects
Xu et al. (2019) Mice BPA (30 or
300 µg/kg)
• Exposure to low BPA dose resulted in increased Bacteroidetes in
non-obese diabetic female mice. Exposure to high dose increased
unclassified bacteria from Rikenellacaea and decreased unclassified
bacteria from Bacteroidales and Lactobacillus.
• Sub-acute exposure in males resulted in an increase in bacteria
classified as other at the phylum level was significantly increased from
the low dose, while Tenericutes was significantly decreased in both BPA
doses of exposure. At the genus level, exposure to high BPA dose
increased Odoribacter and unclassified Campylobacterales and
decreased Anaeroplasma and Camplybacter, while Lactobacillus was
decreased at low BPA dose.
• BPA accelerated the development of T1D in female mice, but delayed the
development of the disease in males.
• The gut microbiome profile was consistently pro-inflammatory in females, but
males had an overall decrease in anti-inflammatory and pro-inflammatory gut
microbes.




• Increased Lachnoclostridum abundance.
• Decreased Akkermansia, Odoribacter and Clostridium sensu stricto.
• Diethylhexyl phthalate promoted p-cresol production but inhibited butyrate
synthesis.
• Exposure to diethylhexyl phthalate could be involved in neurodevelopmental
disorders associated with dysbiosis.
Adamovsky et al. (2020) Zebrafish DEHP
(3mg/kg)
• Diethylhexyl phthalate exposure increased Bacteroidiales and
Gammaproteobacteria and decreased Verrucomicrobiae in males and
females.
• In males the abundance of Fusobacteria and Betaproteobacteria
increased and Saccharibacteria decreased.
• Exposure in males negatively affected several membrane transport proteins,
organic anion transporting polypeptides encoded by slc genes.
• Altered metabolites detected by intestinal and immune Th cells.











• Sprague-Dawley rats showed an increase in the
Firmicutes/Bacteroidetes ratio and in the abundance of Proteobacteria.
• In C57LB/6J mice Proteobacteria and Actinobacteria showed a
downward trend. Tenericutes showed only a significant increase in
cecal content. At the genus level, a decreased abundance of Prevotella,
Lachnospiraceae, and Desulfovibrio was found.
• In BALB/c mice only Bacteroides decreased, while Runimococcaceae
and Rikenellaceae showed a significant increase.
• Wistar rats showed increased abundance of Adlercreutzia,
Eubacateriaceae and Roseburia, and a decrease of Coprococcus,
Dehalobacteiaceae.
• Sprague-Dawley rats were more sensitive to exposure to DEHP with more
severe organic damage, the highest Th1 inflammatory response and highest
increase in body weight. Liver index increased in the medium and high dose
groups. IL-2, IFN-γ, and TNF-α increased significantly and testosterone
decreased.
• In mice, only C57LB/6J mice exposed to high dose showed a higher liver
index. Alanine aminotransferase, aspartate aminotransferase,
alkalinephosphatase levels increased markedly in the highest dose group.
• In Wistar rats, exposure to DEHP induced only a significant increase of
alanineaminotransferase in the low and medium dose groups.
• In BALB/c mice testosterone concentration decreased.
Studies in humans





• Firmicutes/Bacteroidetes ratios changed significantly.
• Bifidobacterium longum, Rothia spp. and Veillonella decreased.
• Rothia and Veillonella abundance has been associated with a lower incidence
of asthma.
• Early exposure to diethylhexyl phthalate can alter the immune response in
adulthood.
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Helicobacteraceae and decreased Firmicutes and Clostridia
populations were observed in BPA-fed mice. In a mouse model,
Javurek et al. (2016) used 16s rRNA sequencing to show that BPA
exposure, especially during development, results in generational
and sex-related changes in the gut microbiome. Exposure to BPA
induced in the parents and their offspring the growth of bacteria
related to an increased risk of inflammatory bowel disease (IBD),
metabolic disorders, and colorectal cancer. Also, in a murine
model, Malaise et al. (2017) observed that perinatal exposure
to BPA promoted disturbances in gut microbiota and immune
system through a decrease in the Th1/Th17 cell frequencies in the
lamina propria as well as an increase of Th1 andTh17 responses
in the spleen. These early-life alterations are associated with
impaired glucose sensitivity and IgA secretion into feces, and a
drop of fecal bifidobacteria versus non-exposed mice.
Chen et al. (2018a) found that simultaneous exposure to
titanium dioxide nanoparticles and BPA in zebrafish resulted
in growth and gut microbiota alterations including loss of
the mucosal barrier integrity and increased inflammation and
oxidative stress. In addition, the changes in gut microbiota were
sex- and concentration-dependent. The authors also found a
correlation between zebrafish body weight and abundances of
Bacteroides, which was also closely associated with the genera
Anaerococcus, Finegoldia, and Peptoniphilus. They also reported
that BPA at low concentrations interacts antagonistically with
titanium dioxide but BPA at higher concentrations interacts
synergistically. Lai et al. (2016) found that dietary BPA exposure
in mice resulted in changes in gut microbiota structure similar
to those found in mice on high-fat and high-sucrose diets. Xu
et al. (2019) described that the effects of BPA-exposure on type
1 diabetes (T1D) in non-obese diabetic mice and found that
were sex- age-dependent with changes in gut microbiota and
inflammation being the main mechanisms disease worsening
in juvenile exposure, while decreased inflammation resulted in
attenuated T1D in perinatally exposed females.
In a mouse model Lei et al. (2019) showed that exposure
to diethylhexylphthalate (DEP), a chemical associated
with neurodevelopmental disorders, led to changes in gut
microbial structure and metabolite profile. These changes
in the microbiota may activate the production of p-cresol, a
potentially toxic metabolite that has also been correlated with
neurodevelopmental disorders. Recently, Adamovsky et al.
(2020) showed that DEP exposure results in alterations in the
microbiome-gut-immune axis which promotes adverse effects
of DEHP on the host by altering metabolites sensed by both
intestinal and immune T-cells. Wang et al. (2020) postulate
that the differences in the toxicity of DEP on different strains
and species of rodents are related to the distinctive DEP-
induced changes in gut. Lastly, Yang et al. (2019) investigated
whether phthalate exposure in newborns through medical
treatment that required intravenous infusions had an impact
on gut microbiota composition and diversity and found that
this type of exposure caused gut dysbiosis, with decreased
Rothia sp. and Bifidobacterium longum. The authors conclude
that early-life exposure to DEP alters gut microbiota in
newborns and may result in disruptions of immune responses
later in life.
Metals
Many heavy metals have shown endocrine disrupting properties,
and human exposure occurs through diet and water, inhalation of
polluted air, smoking and dermal absorption (Sabra et al., 2017).
The effects of metal exposure on the gut microbiota have been
studied in various species including mice, rats, chickens, fish, and
humans in adulthood (Table 4).
Recent works have described the effects of metals on
microbiota including the paper by Zhou et al. (2020) reported
that subchronic exposure to mercury in chickens caused dysbiosis
and altered microbial growth and development, which may
ultimately led to metabolic disorders. Zhao et al. (2020) showed
that mercury exposure in mice resulted in alterations in microbial
growth and development, metabolic disorders, and promoted
apoptosis in mice. Gut dysbiosis was associated with increased
abundance of Coprococcus, Oscillospira and Helicobacter and
reduced Lgnatzschineria, Salinicoccus, and Bacillus.
Ruan et al. (2019) reported that high exposure to copper
and mercury in female mice led to histopathological lesions and
changed the diversity of the cecal microbiota. In an amphibian
model, Zheng et al. (2020) investigated the effects of exposure
to copper, cadmium and chrome on the gut microbiota and
found that at the phylum level, copper exposure increased
Proteobacteria, that has been described to be associated with
metabolic diseases (Rizzatti et al., 2017). Copper, cadmium and
chrome exposure significantly increased Bacteroidetes that is
implicated in the protein metabolism and in the complex cycling
of carbon (He et al., 2018). Lastly, exposure to copper and
cadmium resulted in a reduction of Fusobacteria. The abundance
of Fusobacteria is negatively related to the incidence of infectious
and diseases producing tissue necrosis (Knutie et al., 2018).
Zhang et al. (2020) found that exposure to cadmium
in crustacean P. clarkii resulted in histological changes in
the intestines and alteration of the richness, diversity, and
composition of its gut microbiota with changes in the
relative abundances of Firmicutes, Proteobacteria, Bacteroidetes,
Fusobacteria, and Actinobacteria. Yan et al. (2020) investigated
the toxicity of environmentally relevant concentrations of metals
and microplastics on the gut bacteria and gonadal development
in medaka fish and found significant changes in gut microbiota.
The authors also reported that the exposure to metals increased
the diversity and abundance of intestinal microbiota, in particular
of Proteobacteria. In an epidemiologic study Shao and Zhu
(2020) found that long-term exposure to arsenic, cadmium,
copper, lead and zinc increased the relative abundances of
Lachnospiraceae, Eubacterium eligens, Ruminococcaceae UGG-
014, Erysipelotrichaceae UCG-003, Tyzzerella 3, Bacteroides,
Slackia, and Roseburia and decreased Prevotella. The authors
also reported that these changes in the microbiota were sex-
dependent. Richardson et al. (2018) reported that the microbiota
can be used as a pre-clinical marker of exposure to specific heavy
metals. They described significant changes in the gut microbial
composition in rats after exposure to high doses of chromium and
cobalt, and dose-dependent changes after exposure to arsenic,
cadmium and nickel.
There are few studies that examine the effects of
metal exposure in human microbiota. In this respect,





















TABLE 4 | Studies linking exposure to metals and gut microbiota changes.




Chickens Mercuric chloride (250 mg/L) • At the phylum level, at 30 days there was an increase
in the abundance of Proteobacteria and Tenericutes
phyla, while Tenericutes phylum increased significantly
at 60 days.
• Exposure to mercury reduced body weight.
• Possible induction of metabolic disorders




Kunming mice Mercuric chloride (0 and
80 mg/L)
• Increased abundance Coprococcus, Oscillospira, and
Helicobacter.
• Decreased Lgnatzschineria, Salinicoccus, and
Bacillus.
• Increased body weight and glucose levels.
• Intestinal injury.
• Significantly increased expression of pro-apoptotic
genes (Bax, JNK, ASK1, caspase3, and TNF-α), and






Cu and Hg Decreased abundance of Rikenella, Jeotgailcoccus and
decreased abundance of Staphylococcus.
Corynebacterium increased significantly in mice
exposed to Cu.
• Decreased abundance of Sporosarcina,
Jeotgailcoccus and decreased abundance of
Staphylococcus in the Hg and Cu+Hg groups.
Anaeroplasm increased significantly in the Cu+Hg
group.
• Increased thickness of muscularis internal and
externa.
• Widened submucosa.
• Reduction of goblet cells.
• Necrosis of enterocytes.





Cu (32 and 64 µg/L), Cr (104
and 416 µg/L), Cd (100 and
200 µg/L), NO3 -N (20 and
100 mg/L).
Exposure to NO3 -N, Cd, and Cu increased the
abundance of Proteobacteria.
• Exposures to Cu, Cd, Cr, NO3 –N increased the
abundance of Bacteroidetes.
• Exposure to Cu and Cd decreased the abundance of
Fusobacteria.
• Exposure to NO3 -N increased the risk of developing






Cd (0, 2, 5, and 10 mg/L) Firmicutes, Proteobacteria, Bacteroidetes, and
Fusobacteria were the predominant phyla in the gut
microbiota after exposure to Cd.




O. melastigma Pb (50 µg/L), Cd (10 µg/L),
and Zn (100 µg/L)
Increased abundance of Firmicutes
(Lachnoclostridium-10, Ruminococcaceae and
Lactobacillus), Proteobacteria (Burkholderiales and
Pseudomonas), and Bacteroidetes were observed in
females treated with Pb, Cd, and Zn.
• The gut microbiota of adult males was more sensitive
to exposure to Pb, Cd, and Zn than that of females.










As (15, 22, or 31 mg/kg), Cd
(35, 54, or 85 mg/kg), Co (27,
47, or 82 mg/kg), Cr (44, 62, or
88 mg/kg), Ni (177, 232, or
300 mg/kg)
Exposure to metals resulted in disturbed gut microbiota
composition, but the specific taxa affected were not
consistent.
• The Proteobacteria phylum (Enterobactericeae)
increased in abundance in response to exposure to
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Eggers et al. (2019) examined the association between lead
concentration in urine and gut composition in adults and found
that increased lead levels were correlated with increased α-
diversity and richness. In addition, differences in Proteobacteria,
including members of Burkholderiales, as well as in β-diversity
were significantly associated (p = 0.003) with differences in lead
levels in urine.
Triclosan, Parabens
Triclosan (TCS) is a well-known EDC added to many consumer
products intended to reduce or prevent bacterial contamination
(Halden et al., 2017). Parabens are widely used as preservatives
in cosmetics, personal care products, drugs, and foods (Quiros-
Alcala et al., 2018). Triclosan and parabens have been showed to
alter microbiota in different studies (Table 5). Hu et al. (2016)
examined the effect of low-dose exposure to DEP, methylparaben
(MPB), TCS and the effect of simultaneous exposure (MIX) in
the gut bacterial composition in adolescent rats and found an
increased relative abundance of Bacteroidetes (Prevotella) and
reduced relative abundance of Firmicutes (Bacilli) in exposed rats
versus controls. The authors also found an increased abundance
of Elusimicrobia in rats exposed simultaneously to DEP and
MPB, increased Betaproteobacteria in simultaneous exposure
to MPB and MIX, and Deltaproteobacteria in TCS-exposed
rats. Surprisingly, these differences in gut bacterial composition
decreased diminished by adulthood despite continued exposure,
suggesting that environmental exposure to these chemicals
during adolescence has a strongest effect on the gut microbiome.
They also observed that exposure during adolescence, especially
to DEP and MPB, led to a slight but consistent reduction in the
bodyweight, consistent with the reduced Firmicutes/Bacteroidetes
ratio found in exposed adolescent rats. It has been reported
that the gut microbiota of obese animals and humans shows
a higher Firmicutes/Bacteroidetes ratio compared with normal-
weight individuals, suggesting this ratio as a biomarker. However,
the actual evidence of this association is not convincing
(Magne et al., 2020).
In a zebrafish model Gaulke et al. (2016) found that TCS
exposure resulted in alterations in the composition and ecological
dynamics of gut microbial communities. TCS exposure was also
related to rapid changes in microbiome structure and diversity,
with disturbance of Enterobacteriaceae. TCS-induced changes in
gut microbiota have also been found in other animal models,
including fathead minnows (Narrowe et al., 2015), rats (Hu et al.,
2016), and mice (Gao et al., 2017; Yang et al., 2018).
In contrast, only few studies have investigated the effects of
TCS exposure on the gut microbiota in humans. Bever et al.
(2018) found that fecal microbiota diversity in infants exposed
to triclosan through to breast milk was different from that found
in infant fed milk with non-detectable levels of TCS. In addition,
higher relative abundance of genus Dermabacter was observed
in children exposed to breast milk containing TCS. Ribado et al.
(2017) reported that chronic exposure to TCS through toothpaste
increased the relative abundance of broadly antibiotic-resistant
Proteobacteria species in adults and in children with high TCS
levels in urine.





















TABLE 5 | Studies linking exposure to triclosan and parabens and microbiome changes.
References Animal model Triclosan and
Paraben dose
Microbiota changes Health effects
Studies in animals
Gaulke et al. (2016) Zebrafish TCS (100 µg/g) • Exposure to TCS led to a slight reduction in diversity, with significant
decreases in α-diversity between days 4 and 7 in exposed fish.
• Reduced abundance of Enterobacteriaceae and increased
abundance of Pseudomonas.
_
Narrowe et al. (2015) Fathead minnow TCS (100 and
1,000 ng/L)
• Increase in α-diversity associated with TCS exposure. • Exposure to TCS may induce
long-term effects on the host organism.
Hu et al. (2016) Sprague-Dawley rats MPB (0.105 mg/kg)
and TCS
(0.05 mg/kg)
• The abundance of Bacteroidetes (Prevotella) and Elusimicrobia
increases in both groups.
• Firmicutes (Bacilli) abundance decreased in both groups.
• Betaproteobacteria abundance increased in the group exposed to
MPB.
• Deltaproteobacteria increased in the group exposed to TCS.
• A subtle but constant reduction in
body weight was observed in the young
rats.
Yang et al. (2018) C57BL/6 male mice TCS (5–80 mg/kg) • Beneficial bacteria like Bifidobacterium were reduced. • Exposure to TCS led to low-grade
colon inflammation and colitis and
increased risk of colon cancer related
to the presence of colitis.
Gao et al. (2017) C57BL/6 mice TCS (2 mg/L) • After 4 weeks of exposure, α-diversity increased but it subsequently
decreased after 9 weeks of exposure.
• The bacterial genes involved in stress
response showed significant
enrichment after exposure to TCS.
• High enrichment of metal resistome in
the gut microbiota, which is related to a
reduced effectiveness of infection
treatment.
Studies in humans
Bever et al. (2018) Infants TCS (exposure
through breast milk)
• Significant increases in the genus Dermabacter, order
Rhodospirillales, and family Rhodospirillaceae were found in babies
exposed to TCS through breast milk.
_
Ribado et al. (2017) Infants and their mothers TCS (environmental
exposure and
through breast milk)
• Enrichment of the phylum Proteobacteria in mothers exposed to
TCS-containing toothpaste.
• Enrichment of Proteobacteria in infants with higher TCS levels.
_








































TABLE 6 | Studies linking exposure to polybrominated diphenyl ethers and microbiota changes.
References Animal model PBDE dose Microbiota changes Health effects
Studies in animals
Chen et al. (2018b) Zebrafish PBDE mixture (DE-71)
(5 ng/L)
• Higher relative abundance of Firmicutes and Bacteroidetes in the gut of
male fish, but a lower Firmicutes/Bacteroidetes ratio was observed.
• DE-71 led to decreased Bacteroidetes in the gut of female fish with a
higher Firmicutes/Bacteroidetes ratio.
• Mycoplasma, Ruminiclostridium, unclassified Firmicutes sensu stricto and
Fusobacterium were not detected in the gut of male and female fish.
• In males, an alteration in intestinal health was
observed due to exposure to DE-71, which led
to disruptions of the neural signaling, of the
integrity of the epithelial barrier, inflammatory
response, oxidative stress and antioxidant
capacity, as well as disruptions of the
detoxifying capacity.
• In females, the physiological activities of the
intestine remained unchanged.
Wang et al. (2018) Mice PBDE-47 (0, 0.002 and
0.2 mg/kg)
• Exposure resulted in decreased abundance of Bacteroidetes and
Proteobacteria and in an increase of Actinobacteria at the phylum level.
• Exposure resulted in increased abundance of
Candidatus_Saccharimonas, Ruminococcaceae_UCG-013,
Staphylococcus, Gemella, Eubacterium_nodatum_group,
Corynebacterium_1 and Paenalcaligenesen and in a decrease in the
abundance of Turicibacter and Anaerotruncus at the genus level.
• High fat diet-induced obesity increased as a
result of the exposure to BDE-47.
• Steatosis of the liver, disturbances in glucose
homeostasis, metabolic dysfunction, and
altered levels of gene mRNAs involved in lipid
metabolism were found in mice fed high-fat diet
and exposed BDE-47.
Li et al. (2017) Male C57BL/6 mice PBDE-47 (10–100
µmol/kg) and PBDE-99
(10–100 µmol/kg)
_ • Absence of gut microbiome increased
PBDE-99-mediated upregulation of many
genes involved in drug metabolism and it also
affected hydroxylation of PBDEs.
• Exposure to PBDE increased unconjugated
bile acids in multiple bio-compartments in a gut
microbiota-dependent manner.
Studies in humans




• Exposure to PBDE-99 was associated with a decrease in uncultured
bacteria within the Ruminococcaceae NK4A214 group and exposure to
PBDE-47 led to differences in Ruminococcus 2.
_





















fmicb-11-578007 November 24, 2020 Time: 16:20 # 17
Aguilera et al. Endobolome, Microbiota, and Endocrine Pathogenesis
Polybrominated Diphenyl Ethers (PBDEs)
PBDEs are environmentally persistent chemicals widely used
as flame retardants (Poston and Saha, 2019) that have
been shown to alter microbiota (Table 6). In a zebrafish
model, Chen et al. (2018b) showed that exposure to
environmentally realistic concentrations of PBDEs resulted
in alterations in the gut microbial community in a sex-
dependent manner, significantly affecting zebrafish health. Wang
et al. (2018) found that perinatal exposure to bromodiphenyl
ether (BDE-47) in an obese rat model led to obesity,
hepatic steatosis, and dysfunctional glucose homeostasis
and metabolism. The authors also reported that exposure
to BDE-47 led to changes in gut microbiota diversity and
composition, and microbial metabolism. These exposure-
related changes were stronger in mice on a high-fat diet.
These findings suggest that early life exposure to BDE-47 at
low doses of may stimulate obesity and the development of
metabolic dysfunction.
Li et al. (2017) investigated whether exposure to PBDEs
is associated with dysbiosis in standard and germ-free mice
and reported that PBDE exposure resulted in a significant
decrease in the alpha diversity of gut microbiome and
modulated 45 bacterial species with increased Akkermansia
muciniphila and Erysipelotrichaceae Allobaculum spp., which
have shown antiinflammatory and antiobesity capacity.
Lastly, they also found that PBDE exposure increased the
amount of unconjugated bile acids in a gut microbiota-
dependent manner.
Laue et al. (2019) compared the effects of PBDE perinatal
exposure on the gut microbiome profiles with the effects of
exposure in mid-childhood. Higher PBDE concentrations were
related to lower abundances of uncultured bacteria in the
Ruminococcaceae NK4A214 group and with variable abundances
of Ruminococcus 2 species. These changes at the taxon-level did
not lead to differences in within- or between-subject diversity.
Lastly, exposures at delivery were not linked to differences in taxa.
CONCLUSION
Endogenous steroid hormones and EDC interact with gut
microbiota through different pathways: (i) they could be directly
metabolized by the gut microbiota after ingestion or after being
conjugated in the liver, and (ii) they can interfere with the
composition and/or metabolic activity of the gut microbiota.
Both interactions may have an effect in host health. We propose
that toxicological studies should consider the changes in the
gut microbiota related to contaminant exposure and term the
chemicals having an effect on gut microbiota as “microbiota
disrupting chemicals.” The risk of developing certain disorders
associated with gut microbiota changes should be established by
determining both the effects of the MDC on gut microbiota and
the impact of microbiota changes on chemicals metabolism and
host susceptibility.
Gut microbiota composition used in combination with the
determination of serum, urinary and fecal levels of estrogens
can be used as susceptibility or risk biomarkers for disease.
Profiling of the gut microbiome could be taken a step
further by performing metagenomic analysis to determine
the levels of genes encoding β-glucuronidases and other
enzymes involved in hormone metabolism in the context of
hormone-related diseases. Novel hormone modulation methods
involving modifications of the microbiome or control of
hormone and EDC exposure may be very effective and provide
an alternative to current treatments of hormone-dependent
disorders. Additionally, the therapeutic effects of bacteria on the
endobolome, which cluster biosynthetic and metabolic arsenal
for estrogens, steroid hormones and/or endocrine disruptor
chemicals, should also be considered for the design and
development of biotherapeutic products. The endobolome plays
a central role in the gut microbiota as seen by the amount of
potentially endobolome-mediated diseases and thereby it can be
considered an attractive diagnostic tool and therapeutic target
for future research strategies that envisage the use of next
generation of probiotics.
In any case, further animal controlled experiments, clinical
trials and large epidemiological studies are required in order to
establish the concatenated impact of the microbial disrupting
chemical-microbiota-host health axis.
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